QHSLab (QHSLab) FCF Margin % : -42.86% (As of Dec. 2023)

View and export this data going back to 1990. Start your Free Trial

What is QHSLab FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. QHSLab's Free Cash Flow for the three months ended in Dec. 2023 was $-0.14 Mil. QHSLab's Revenue for the three months ended in Dec. 2023 was $0.32 Mil. Therefore, QHSLab's FCF Margin % for the quarter that ended in Dec. 2023 was -42.86%.

As of today, QHSLab's current FCF Yield % is -18.93%.

The historical rank and industry rank for QHSLab's FCF Margin % or its related term are showing as below:

USAQ' s FCF Margin % Range Over the Past 10 Years
Min: -158.4 Med: -33.64 Max: -11.28
Current: -11.28

During the past 13 years, the highest FCF Margin % of QHSLab was -11.28%. The lowest was -158.40%. And the median was -33.64%.

USAQ's FCF Margin % is ranked worse than
54.24% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: -7.29 vs USAQ: -11.28

QHSLab FCF Margin % Historical Data

The historical data trend for QHSLab's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab FCF Margin % Chart

QHSLab Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-158.40

-36.07

-31.21

-11.36

QHSLab Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-26.12	0.57	-9.63	3.87	-42.86

Competitive Comparison of QHSLab's FCF Margin %

For the Medical Devices subindustry, QHSLab's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QHSLab's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's FCF Margin % distribution charts can be found below:

* The bar in red indicates where QHSLab's FCF Margin % falls into.

QHSLab FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

QHSLab's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.16	/	1.409
	=	-11.36 %

QHSLab's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.135	/	0.315
	=	-42.86 %

QHSLab FCF Margin % Related Terms

Thank you for viewing the detailed overview of QHSLab's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

QHSLab (QHSLab) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407

Website

https://www.qhslab.com

QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.

Executives

Troy James Grogan	director, 10 percent owner, officer: CEO/Director	5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin	director, 10 percent owner, officer: CEO & Chairman	90 JOHN STREET, SUITE 626, NEW YORK NY 10038